Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA

Journal of the American Society of Nephrology

Volumn 16, Issue 2, 2005, Pages 340-351

  Wahab, Nadia Abdel ^a,b   Weston, Benjamin S ^a   Mason, Roger M ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,3' DITHIOBIS(SUCCINIMIDYL PROPIONATE); CELL SURFACE PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTROPHIN RECEPTOR; PHOSPHOTYROSINE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE B; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN TYROSINE KINASE A; STRESS ACTIVATED PROTEIN KINASE; CROSS LINKING REAGENT; IMMEDIATE EARLY PROTEIN; MESSENGER RNA; SIGNAL PEPTIDE;

ARTICLE; CELL CULTURE; CROSS LINKING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MESANGIUM CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ADULT; BINDING SITE; CYTOLOGY; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; MESANGIUM; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

ADULT; BASE SEQUENCE; BINDING SITES; BLOTTING, WESTERN; CELLS, CULTURED; CROSS-LINKING REAGENTS; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULAR MESANGIUM; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; RECEPTOR, TRKA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 20444384532     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2003100905     Document Type: Article

References (59)

1. Bork P: The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327: 125-130, 1993
2. Wahab NA, Yevdokimova N, Weston BS, Roberts T, Li XJ, Brinkman H, Mason RM: Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J 359: 77-87, 2001
3. Takigawa M: CTGF/Hcs24 as a multifunctional growth factor for fibroblasts, chondrocytes and vascular endothelial cells. Drug News Perspect 16: 11-21, 2003
4. Abreu JG, Ketpura NI, Reversade B, De Robertis EM: Connective-tissue growth factor (CTGF) modulates cell signaling by BMP and TGF-beta. Nat Cell Biol 4: 599-604, 2002
5. Babic AM, Chen CC, Lau LF: Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin αvβ3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 19: 2958-2966, 1999
6. Chen N, Chen CC, Lau LF: Adhesion of skin fibroblasts to Cyr61 is mediated through integrin α6β1 and cell surface heparin sulfate proteoglycans. J Biol Chem 275: 24953-24961, 2000
7. Crean JK, Finlay D, Murphy M, Moss C, Godson C, Martin F, Brady HR: The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells. J Biol Chem 277: 44187-44194, 2002
8. Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF, Lam SC: Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin α(IIb)β(3). J Biol Chem 274: 24321-24327, 1999
9. Leu SJ, Lam SC, Lau LF: Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins αvβ3 and α6β1 in human umbilical vein endothelial cells. J Biol Chem 277: 46248-46255, 2002
10. Schober JM, Chen N, Grzeszkiewicz TM, Jovanovic I, Emeson EE, Ugarova TP, Ye RD, Lau LF, Lam SC: Identification of integrin α(M)β(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): Immediate-early gene products expressed in atherosclerotic lesions. Blood 99: 4457-4465, 2002
11. Wahab NA, Mason RM: Connective tissue growth factor and renal disease: Some answers, more questions. Curr Opin Nephrol Hypertens 13: 53-58, 2004
12. Johnsen SA, Subramaniam M, Janknecht R, Spelsberg TC: TGFβ inducible early gene enhances TGFβ/Smad-dependent transcriptional responses. Oncogene 21: 5783-5790, 2002
13. Nishida T, Nakanishi T, Shimo T, Asano M, Hattori T, Tamatani T, Tezuka K, Takigawa M: Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8). Biochem Biophys Res Commun 247: 905-909, 1998
14. Segarini PR, Nesbitt JE, Li D, Hays LG, Yates JR 3rd, Carmichael DF: The low density lipoprotein receptor-related protein/α2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem 276: 40659-40667, 2001
15. Segal RA: Selectivity in neurotrophin signaling: Theme and variations. Annu Rev Neurosci 26: 299-330, 2003
16. Lazarovici P, Levi BZ, Lelkes PI, Koizumi S, Fujita K, Matsuda Y, Ozato K, Guroff G: K-252a inhibits the increase in c-fos transcription and the increase in intracellular calcium produced by nerve growth factor in PC12 cells. J Neurosci Res 23: 1-8, 1989
17. Nikodijevic B, Guroff G: Nerve growth factor-induced increase in calcium uptake by PC12 cells. J Neurosci Res 28: 192-199, 1991
18. Huang EJ, Reichardt LF: TRK receptors: Roles in neuronal signal transduction. Annu Rev Biochem 72: 609-642, 2003
19. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: Activation, co-stimulation, and death. Cell 76: 959-962, 1994
20. NTR with Trk receptors. J Biol Chem 270: 22135-22142, 1995
21. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhauser N, Bohm-Matthaei R, Baeuerle PA, Barde YA: Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 272: 542-545, 1996
22. Casaccia-Bonnefil P, Kong H, Chao MV: Neurotrophins: The biological paradox of survival factors eliciting apoptosis. Cell Death Differ 5: 357-364, 1998
23. Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV: High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 350: 678-683, 1991
24. Esposito D, Patel P, Stephens RM, Perez P, Chao MV, Kaplan DR, Hempstead BL: The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor. J Biol Chem 276: 32687-32695, 2001
25. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV: Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383: 716-719, 1996
26. Lee R, Kermani P, Teng KK, Hempstead BL: Regulation of cell survival by secreted proneurotrophins. Science 294: 1945-1948, 2001
27. Grimes ML, Beattie E, Mobley WC: A signaling organelle containing the nerve growth factor-activated receptor tyrosine kinase, TrkA. Proc Natl Acad Sci U S A 94: 9909-9914, 1997
28. Beattie EC, Zhou J, Grimes ML, Bunnett NW, Howe CL, Mobley WC: A signaling endosome hypothesis to explain NGF actions: Potential implications for neurodegeneration. Cold Spring Harb Symp Quant Biol 61: 389-406, 1996
29. Howe CL, Valletta JS, Rusnak AS, Mobley WC: NGF signaling from clathrin-coated vesicles: Evidence that signaling endosomes serve as a platform for the Ras-MAPK pathway. Neuron 32: 801-814, 2001
30. Anderson RA, Robinson LL, Brooks J, Spears N: Neurotrophins and their receptors are expressed in the human fetal ovary. J Clin Endocrinol Metab 87: 890-897, 2002
31. Datta SR, Brunet A, Greenberg ME: Cellular survival: A play in three Akts. Genes Dev 13: 2905-2927, 1999
32. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S: Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A 95: 11211-11216, 1998
33. Berg MM, Sternberg DW, Parada LF, Chao MV: K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity. J Biol Chem 267: 13-16, 1992
34. Barker PA, Hussain NK, McPherson PS: Retrograde signaling by the neurotrophins follows a well-worn trk. Trends Neurosci 25: 379-381, 2002
35. Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, Graziani A, Panayotou G, Comoglio PM: A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77: 261-271, 1994
36. Wang LH, Besirli CG, Johnson EM: Mixed-lineage kinases: A target for the prevention of neurodegeneration. Annu Rev Pharmacol Toxicol 44: 451-474, 2004
37. Wahab NA, Brinkman H, Mason RM: Uptake and intracellular transport of the connective tissue growth factor: A potential mode of action. Biochem J 359: 89-97, 2001
38. Geetha T, Wooten MW: Association of the atypical protein kinase C-interacting protein p62/ZIP with nerve growth factor receptor TrkA regulates receptor trafficking and Erk5 signaling. J Biol Chem 278: 4730-4739, 2003
39. Perez P, Coll PM, Hempstead BL, Martin-Zanca D, Chao MV: NGF binding to the trk tyrosine kinase receptor requires the extracellular immunoglobulin-like domains. Mol Cell Neurosci 6: 97-105, 1995
40. Terenghi G, Mann D, Kopelman PG, Anand P: trkA and trkC expression is increased in human diabetic skin. Neurosci Lett 228: 33-36, 1997
41. Alpers CE, Hudkins KL, Ferguson M, Johnson RJ, Schatteman GC, Bothwell M: Nerve growth factor receptor expression in fetal, mature, and diseased human kidneys. Lab Invest 69: 703-713, 1993
42. Alpers CE, Hudkins KL, Floege J, Johnson RJ: Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 5: 201-209, 1994
43. Ehrhard PB, Erb P, Graumann U, Otten U: Expression of nerve growth factor and nerve growth factor receptor ty kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci U S A 90: 10984-10988, 1993
44. Brodie C, Gelfand EW: Functional nerve growth factor receptors on human B lymphocytes. Interaction with IL-2. J Immunol 148: 3492-3497, 1992
45. Caroleo MC, Costa N, Bracci-Laudiero L, Aloe L: Human monocyte/macrophages activate by exposure to LPS overexpress NGF and NGF receptors. J Neuroimmunol 113: 193-201, 2001
46. Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, Bonini S, Maquart FX, Aloe L, Levi-Schaffer F: Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A 98: 6162-6167, 2001
47. Yaar M, Eller MS, DiBenedetto P, Reenstra WR, Zhai S, McQuaid T, Archambault M, Gilchrest BA: The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest 94: 1550-1562, 1994
48. Iannone F, De Bari C, Dell'Accio F, Covelli M, Patella V, Lo Bianco G, Lapadula G: Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes. Rheumatology (Oxford) 41: 1413-1418, 2002
49. Seidah NG, Benjannet S, Pareek S, Savaria D, Hamelin J, Goulet B, Laliberte J, Lazure C, Chretien M, Murphy RA: Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. Biochem J 314: 951-960, 1996
50. Suter U, Heymach JV Jr, Shooter EM: Two conserved domains in the NGF propeptide are necessary and sufficient for the biosynthesis of correctly processed and biologically active NGF. EMBO J 10: 2395-2400, 1991
51. Dicou E, Pflug B, Magazin M, Lehy T, Djakiew D, Ferrara P, Nerriere V, Harvie D: Two peptides derived from the nerve growth factor precursor are biologically active. J Cell Biol 136: 389-398, 1997
52. Fahnestock M, Michalski B, Xu B, Coughlin MD: The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 18: 210-220, 2001
53. Ball DK, Surveyor GA, Diehl JR, Steffen CL, Uzumcu M, Mirando MA, Brigstock DR: Characterization of 16- to 20-kilodalton (kDa) connective tissue growth factors (CTGFs) and demonstration of proteolytic activity for 38-kDa CTGF in pig uterine luminal flushings. Biol Reprod 59: 828-835, 1998
54. McDonald NQ, Hendrickson WA: A structural superfamily of growth factors containing a cystine knot motif. Cell 73: 421-424, 1993
55. Bradham DM, Igarashi A, Potter RL, Grotendorst GR: Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114: 1285-1294, 1991
56. Lai KO, Fu WY, Ip FC, Ip NY: Cloning and expression of a novel neurotrophin, NT-7, from carp. Mol Cell Neurosci 11: 64-76, 1998
57. Li X, Franz J, Lottspeich F, Gotz R: Recombinant fish neurotrophin-6 is a heparin-binding glycoprotein: Implications for a role in axonal guidance. Biochem J 324: 461-466, 1997
58. Bamji SX, Majdan M, Pozniak CD, Belliveau DJ, Aloyz R, Kohn J, Causing CG, Miller FD: The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J Cell Biol 140: 911-923, 1998
59. Chao MV, Bothwell M: Neurotrophins: To cleave or not to cleave. Neuron 33: 9-12, 2002